Thymosin A1 to help protect organs after emergency aortic surgery
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at whether thymosin A1 can reduce immune-related problems and organ injury after emergency surgery for an acute aortic condition. If you qualify, you may receive thymosin A1 as part of the treatment plan to see if it improves recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with a sudden aortic problem (an “acute aortic syndrome”) within about 2 weeks of when symptoms started, based on clinical exam and scans.
- You are currently being planned for emergency surgery for the aortic condition.
- You are between 18 and 90 years old.
- You are able and willing to sign the study consent form.
- You do not have a known allergy to thymosin A1.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an “add-on” anti-inflammatory approach can help after surgery for certain problems affecting the aorta (the body’s main artery) soon after symptoms begin. It may be designed to reduce inflammation-related complications in people who are treated quickly and can join follow-up.
This study tests whether a simple blood test (D-dimer) combined with a risk score can safely identify patients who do not have a life-threatening tear in the aorta (the main artery from the heart). If it works, it could help doctors avoid unnecessary imaging scans and get patients diagnosed faster.
This trial tests whether using your own platelet-rich plasma during open surgery for type A aortic dissection can improve outcomes. If you qualify, you may receive this treatment to help with recovery.
This trial tests whether taking a cholesterol-lowering medicine (a statin) after certain aortic surgeries can reduce harmful changes in the heart and other organs. You might benefit by lowering the risk of ongoing damage after your acute aortic condition and surgery.
This study is testing a new way to quickly diagnose a tear or blood clot in the aorta (the main artery from the heart) by looking at a special score. If you have sudden chest, back, or belly pain, this trial may help find the cause faster.
This trial tests if the drug Sivelestat can protect organs like the heart, kidneys, and lungs after emergency surgery for a severe tear in the main artery from the heart (type A aortic dissection). If you are having this surgery, you may be able to join.
Hear when a new Acute Aortic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.